RNA methylation‐related inhibitors: Biological basis and therapeutic potential for cancer therapy

Documenti analoghi

• Synthetic lethality in cancer therapy: Mechanisms, models and clinical translation for overcoming therapeutic resistance
  di: Junyan Li, et al.
  Pubblicazione: (2026)
• Lactylation in cancer: Mechanisms in tumour biology and therapeutic potentials
  di: Yipeng He, et al.
  Pubblicazione: (2024)
• Immune‐related adverse events in non‐small cell lung cancer: Occurrence, mechanisms and therapeutic strategies
  di: Xuwen Lin, et al.
  Pubblicazione: (2024)
• Copper in colorectal cancer: From copper‐related mechanisms to clinical cancer therapies
  di: Yuhong Wang, et al.
  Pubblicazione: (2024)
• Blockade of V‐domain immunoglobulin suppressor of T‐cell activation reprograms tumour‐associated macrophages and improves efficacy of PD‐1 inhibitor in gastric cancer
  di: Yifan Cao, et al.
  Pubblicazione: (2024)